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properties and eﬀect on the vaginal microbiota
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José Pinela, a Maria José Alves, a Sandrina Heleno, a P. F. Santos *b and
Isabel C. F. R. Ferreira *a
The inﬂorescences of Calluna vulgaris were nutritionally and chemically characterized. Furthermore,
diﬀerent organic and aqueous extracts were prepared for the evaluation of their bioactive properties.
From the obtained results, carbohydrates were the major compounds, followed by protein, lipid and
ashes. It was possible to identify the sugars fructose and glucose, ﬁve organic acids, 26 individual fatty
acids and the four tocopherol isoforms. Concerning the extract composition, 12 phenolic compounds
were identiﬁed, with myricetin-3-O-glucoside and myricetin-O-rhamnoside predominating. Concerning
the bioactive eﬀects, the more polar extracts showed not only the highest amount in phenolic com-
pounds, but also the strongest antioxidant and antibacterial activities. In contrast, for the anti-inﬂamma-
tory and cytotoxic potential, the most eﬀective extracts were the n-hexane and the ethyl acetate extracts,
respectively. C. vulgaris presented a wide range of biological eﬀects, highlighting their capacity to inhibit
pathogenic bacteria without aﬀecting beneﬁcial microﬂora, corroborating their use in traditional medicine.
1. Introduction
Medicinal plants have been widely used by our ancestors as
therapeutic agents. Although traditional medicine is being
used less and less as the first form of treatment, medicinal
plants have gained attention and have been extensively
exploited for their richness in important biomolecules, able to
prevent and treat diﬀerent pathologies through the strengthen-
ing of the immune system or acting directly by inhibiting the
mechanisms of action of these diseases.1 Phenolic com-
pounds, vitamins, carotenoids and lipids are among the most
bioactive molecules found in medicinal plants, directly corre-
lated with their bioactive potential.1
Calluna vulgaris (L.) Hull (syn. Erica vulgaris L.), known in
English as Scotch heather, common heather or ling, is an
acknowledged medicinal plant and is extensively used in folk
medicine, being mostly consumed in the form of infusions or
decoctions. This plant is also used as a condiment,2 and is
usually found in foods, such as honey, providing excellent nec-
tariferous properties.3 C. vulgaris is the only representative of
the genus Calluna, belonging to the order Ericales and to the
Ericaceae family. This plant is native to Europe and North
Africa and was further introduced in Australia, Canada and
the United States of America.4 The flowering season of this
plant usually starts in May and finishes in November. The
inflorescences are very small, of 3 to 4 mm diameter, and have
a short peduncle surrounded at the base by four ciliated brace-
lets. The corolla is rosy, deeply split with four lobes that persist
even after drying.4 It has diﬀerent ethnopharmacological uses,
such as in the treatment of eczema, wounds and acne,5 rheu-
matic pain and arthritis problems,6 and outstanding eﬀects on
the treatment of urinary infections,4,6 disinfecting the urinary
tract and mildly increasing urine production.7 Besides the
mentioned biological eﬀects, diﬀerent extracts of this shrubby
species have been described as having antimicrobial,8–10 anti-
oxidant,11,12 anti-inflammatory,8,13 antinociceptive,13 anti-
viral,14 enzymatic inhibitory activity,8,15 and cytotoxic
capacity.11,16 C. vulgaris presents this wide range of biological
eﬀects due to its richness in bioactive molecules, namely, phe-
nolic compounds, that can be present in higher or lower
amounts depending on the growing conditions such as the
soil, climate and altitude. The presence of these compounds is
crucial to the performance of this species in exerting its bioac-
tivity. This class of compounds is essentially provided with
several OH groups with a strong ability to present antioxidant,
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antibacterial, anti-inflammatory and anti-proliferative pro-
perties.6 Besides phenolic compounds, also triterpenoids,
namely, ursolic and oleanolic acids, were identified and
related with the antitumoral properties of C. vulgaris.14,17
Lupeol and friedelin, with anti-inflammatory, antitumoral and
antimicrobial properties, were identified in flower and leaf
extracts of this shrub.18 The content of amino acids was also
reported and related to the biological properties associated
with this species. Amino acids such glutamic and aspartic
acids, which are important in the neurotransmission process
and also in albumin and globulin constitution, were
identified.19
Considering the literature description of the bioactivity of
this highly appreciated medicinal plant and taking into
account its traditional application in the treatment of urinary
infections, the aims of the present study were to: (i) fully
characterize C. vulgaris in terms of its nutritional value and
chemical composition; (ii) use diﬀerent solvents to select the
most bioactive extracts; (iii) evaluate the biological activities of
the extracts such as antioxidant, anti-inflammatory, cytotoxic
and antimicrobial against pathogenic and non-pathogenic bac-
teria, the latter belonging to the vaginal microbiota.
2. Materials and methods
2.1. Standards and reagents
All the solvents were of analytical grade and obtained commer-
cially from Fisher Scientific (Lisbon, Portugal) and used as
received. The FAME mixture (standard 47885-U) was purchased
from Sigma-Aldrich (St Louis, MO, USA), as also sugar standards,
organic acids, L-ascorbic acid, acetic and formic acid, Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), tri-
chloroacetic acid (TCA), ellipticine, sulphorhodamine B (SRB),
trypan blue and Tris. Phenolic compound standards were pur-
chased from Extra-synthèse (Genay, France). Tocol (50 mg
mL−1) and individual tocopherols were obtained from Matreya
(Pleasant Gap, PA, USA), 2,2-diphenyl-1-picrylhydrazyl (DPPH)
from Alfa Aesar (Ward Hill, MA, USA), fetal bovine serum
(FBS), L-glutamine, Hank’s balanced salt solution (HBSS),
trypsin–EDTA (ethylenediaminetetraacetic acid), penicillin/
streptomycin solution (100 U mL−1 and 100 mg mL−1, respect-
ively), RPMI-1640 and DMEM media were obtained from
Hyclone (Logan, Utah, USA). Other reagents and solvents
(analytical grade) were obtained from common commercial
sources. Water was treated through a Milli-Q water purification
system (TGI Pure Water Systems, Greenville, SC, USA). Tryptic
Soy Broth (TSB) was obtained from Biomerieux (Marcy-l’Étoile,
France). Blood agar with 7% sheep blood and MacConkey agar
plates were purchased from Liofilchem, Italy. The dye p-iodoni-
trotetrazolium chloride (INT) was purchased from Sigma-
Aldrich (Spruce Street; St Louis, MO).
2.2. Plant material
The dried inflorescences of Calluna vulgaris (L.) Hull were
obtained commercially through Girassol, a Portuguese herbal
company. The material was reduced to a fine powder
(∼20 mesh) and the homogeneous sample was stored in a
refrigerator under protection from light.
2.3. Chemical composition of the flowering inflorescences of
C. vulgaris
Nutritional value. The inflorescences were analyzed for their
content of fats, carbohydrates, ashes, proteins and energetic
value using the recommended AOAC procedures,20 and follow-
ing a procedure described previously.21
Free sugars. Free sugars were analyzed by High Performance
Liquid Chromatography (HPLC, Knauer, Smartline system
1000) coupled to a refractive index detector (RI detector,
Knauer Smartline 2300) according to the method described by
the authors.22 Quantification was achieved using calibration
curves obtained for the individual sugars using the internal
standard method (IS, melezitose). Data were analyzed using
Clarity 2.4 software (DataApex) and the results were expressed
in g per 100 g of dry weight.
Organic acids. The organic acid content was assessed by
Ultrafast Liquid Chromatography (UPLC) coupled with a Diode
Array Detector (DAD), according to the conditions formerly
described.23 The identification and quantification were accom-
plished by comparing the retention times and the spectra with
commercial standards and their respective calibration curves.
Data were analyzed using LabSolutions Multi LC-PDA software
and the results were expressed in g per 100 g of dry weight.
Fatty acids. After the transesterification process, the content
of fatty acids was determined using Gas Chromatography (GC)
coupled to a flame ionization detector (FID), according to the
process described by the authors.22 Data were analyzed using
Clarity 2.4 software (DataApex) and the results were expressed
in relative percentage
Tocopherols. The tocopherols were determined using an
HPLC system with a fluorescence detector, according to a
method described by the authors.22 The identification and
quantification were achieved by comparison of the retention
times and the spectra with commercial standards, using the
internal standard methodology (IS, Tocol). Data were analyzed
using Clarity 2.4 software (DataApex) and the results were
expressed in mg per 100 g of dry weight.
2.4. Preparation of the organic and aqueous extracts
The preparation of the organic and aqueous extracts was based
on the procedure previously described by the authors.24 For the
preparation of the organic extracts (n-hexane, dichloromethane,
ethyl acetate, acetone and methanol), 150 g of dried material
were extracted through a successive extraction process, twice
with each organic solvent (750 mL) for 24 h, under vigorous stir-
ring (150 rpm), at room temperature. The extracts were filtered
under reduced pressure through a Whatman No. 541 paper. The
combined organic extracts were evaporated to dryness under
reduced pressure at 40 °C (Büchi R-20, Flawil, Switzerland).
For the decoction preparation, the dried sample (1 g) was
added to 100 mL of distilled water and boiled for 5 minutes;
the mixture was then left for another 5 minutes at room
temperature.
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The infusion extract was obtained by adding the dried
sample (1 g) to 100 mL of boiling distilled water and left to
infuse for 5 minutes at room temperature.
For both of the aqueous extracts, the final extract was fil-
tered under reduced pressure through a Whatman No. 541
paper, frozen at −20 °C and lyophilized (Büchi R-20, Flawil,
Switzerland).
2.5. Phenolic compound analysis
For the phenolic compound analysis, the final extracts of
n-hexane, dichloromethane, acetone and ethyl acetate were re-
dissolved in MeOH and the methanolic extract in MeOH/H2O
(80/20, v/v), to a final concentration of 15 mg mL−1. The
aqueous extracts were re-dissolved in water at a final concen-
tration of 5 mg mL−1. The extracts were further filtered through
0.22 µm nylon syringe filters. The phenolic compounds were
determined by High Performance Liquid Chromatography
coupled to a diode array detector and to mass spectrometry
using electrospray ionization (HPLC-DAD-ESI/MS), as previously
described.25 The phenolic compounds’ tentative identification
was performed correlating their retention times, UV-Vis and
mass spectra data with commercial standards and the available
literature information. For the quantification analysis, the area
of the chromatographic peaks was compared with the cali-
bration curves of the corresponding commercial standards. The
results were expressed as mg per g of dry weight.
2.6. Evaluation of the biological properties
Antioxidant activity. This activity was measured through two
assays: (i) inhibition of lipid peroxidation by the decrease in
thiobarbituric acid reactive substances (TBARS), and (ii) oxi-
dative hemolysis inhibition assay (OxHLIA).
For the TBARS assay, the organic extracts were re-dissolved
in MeOH and the aqueous extracts in water, at a concentration
of 5 mg mL−1. The stock solutions were subjected to successive
dilutions for analysis (0.078–5 mg mL−1). The antioxidant
capacity was measured by the decrease of thiobarbituric acid
reactive substances (TBARS) using porcine (Sus scrofa) brain
homogenates. The colour intensity of malondialdehyde–thio-
barbituric acid (MDA–TBA) was measured by its absorbance at
532 nm, following a procedure described previously.26
For the OxHLIA assay, a known mass of extract (100 mg)
was dissolved in PBS, obtaining diﬀerent solutions ranging
from 12.5 to 125 μg mL−1. To determinate the inhibition
capacity of oxidative hemolysis associated with each of the
tested extracts, an ovine blood sample was obtained from
healthy animals donated by the School of Agriculture,
Bragança, Portugal, and centrifuged for 5 minutes at 1000 rpm
at 10 °C. The plasma and leukocyte supernatants were dis-
carded and the red cell suspension was washed once with a
NaCl solution (150 mM) and three times with phosphate
buﬀered saline (PBS, pH 7.4).27 The erythrocytes were re-sus-
pended in PBS (2.8%, v/v) and an aliquot (200 μL) of this solu-
tion was placed in a 48 well microplate along with an aliquot
(400 μL) of each of the samples, PBS solution (control), or
water (for complete hemolysis). The mixture was then incu-
bated with shaking at 37 °C for 10 minutes. A solution of
AAPH (200 mL, 160 mM in PBS) was added and the plate was
again incubated under the same conditions. The optical
density was measured at 690 nm every 10 minutes28 in order
to determine the percentage of erythrocytes that remained
intact through the following mathematical equation: P(%) =
(St −CH0/S0 − CH0) × 100, where St and S0 relate to the optical
density relative to time t and time 0 (in minutes), respectively,
and CH0 to the optical density of total hemolysis at time
0. The results are expressed in terms of time interval (Δt ) of
hemolysis delay calculated using the formula: Δt (min) =
Ht50 (sample) − Ht50 (control), where Ht50 corresponds to the
time, in minutes, in which there is 50% hemolysis, a value
obtained graphically through the hemolysis curve of each of
the extracts. Then, the Δt values were correlated to the tested
extract concentrations in order to calculate the concentration
required to keep 50% of the erythrocyte population (P) intact
for 60 min.
Anti-inflammatory activity. This bioactivity was evaluated
in vitro using a murine macrophage (RAW 264.7) cell line,
according to a method described previously.29 The organic and
aqueous extracts were re-dissolved in 50% DMSO obtaining
stock solutions with a final concentration of 8 mg mL−1. To
determine the concentration providing 50% inhibition (EC50)
of nitric oxide (NO) production, the stock solutions were sub-
jected to further dilutions (0.125–400 µg mL−1).
Dexamethasone was used as a positive control.
Cytotoxicity. The organic and aqueous extracts were dis-
solved in 50% DMSO, obtaining a stock solution of
8 mg mL−1, which was successively diluted to obtain a range
of concentrations from 0.125 to 400 µg mL−1. This activity was
evaluated against five types of tumor cell lines: AGS – human
gastric adenocarcinoma; MCF-7 – human breast adeno-
carcinoma; NCI-H460 – human non-small lung carcinoma; HeLa
– human cervical carcinoma; and HepG-2 – human hepatocellu-
lar carcinoma. A non-tumor primary culture obtained from
porcine liver cells (PLP2) was also used to analyze the cytotoxic
eﬀects in normal cells. The cytotoxic potential was evaluated
through the sulforhodamine B assay, according to a procedure
described previously.22 Ellipticine was used as a positive control.
Antibacterial activity. This biological activity was evaluated
against Gram-positive bacteria: Enterococcus faecalis isolated
from urine, Listeria monocytogenes isolated from cerebrospinal
fluid, methicillin-resistant Staphylococcus aureus (MRSA) from
expectoration, methicillin-susceptible Staphylococcus aureus
(MSSA) isolated from a wound exudate; and Gram-negative
bacteria: Escherichia coli, Klebsiella pneumoniae and Proteus
mirabilis, isolated from urine, and Morganella morganii and
Pseudomonas aeruginosa isolated from expectoration. All these
microorganisms were provided by the Local Health Unit of
Bragança and Hospital Center of Trás-os-Montes and Alto-
Douro, Vila Real, Northeast of Portugal.
Commercial strains were also tested: pathogenic Gram-
negative – Neisseria gonorrhoeae ATCC 49226, and also non-
pathogenic bacteria usually present in the vaginal microbiota,
variable Gram – Gardnerella vaginalis ATCC 14018 (Liofilchem,
Paper Food & Function
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Italy). Lactobacillus plantarum DSM 12028, Lactobacillus
delbrueckii subs. bulgaricus LMG 6901 and Lactobacillus casei
NCTC 6375, were all donated by the Catholic University of
Porto.
To determine the Minimum Inhibitory Concentrations
(MIC), the organic and aqueous extracts were re-dissolved in
5% DMSO and TSB culture medium, obtaining a final concen-
tration of 20 mg mL−1.
For the evaluation of the eﬀects on the selected vaginal
strains, only the most promising extracts were tested (acetone,
methanol, decoction and infusion), based on the results from
the pathogenic bacteria strains. This activity was assessed by
the microdilution method and the colorimetric assay using
INT (p-iodonitrotetrazolium chlorite, 0.2 mg mL−1).30 Briefly,
190 µL of the stock solution (20 mg mL−1) were added to the
first well of a 96-well microplate. Successive dilutions were
carried out over the wells containing 90 µL of medium.
Afterwards, 10 µL of inoculum (1.5 × 108 CFU mL−1) were
added to all wells containing the tested concentrations in the
range of 0.156–20 mg mL−1.
Three negative controls were prepared (one with TSB
medium, another one with the extract, and a third one with
medium and antibiotic) and a negative control with medium
and inoculum. Ampicillin, imipenem and vancomycin were
the antibiotics used. The plates were then incubated in an
oven (Jouan, Berlin, Germany) at 37 °C for 24 h. The MICs of
the samples were determined after addition of the INT (0.2
mg mL−1, 40 µL) and after incubation at 37 °C for 30 min. The
viable microorganisms reduced the yellow dye to pink. MIC
was defined as the lowest extract concentration that prevented
this change and exhibited the complete inhibition of bacterial
growth. The assays were carried out in triplicate.
2.7. Statistical analysis
The described assays were performed in triplicate and the
results were expressed as the mean ± standard deviation (SD).
The results were obtained by analysis of variance (ANOVA) fol-
lowed by Tukey’s HSD test with α = 0.05. When the results had
less than three samples, they were analyzed through Student’s
t-test in order to determine the significant diﬀerences between
two samples, with p = 0.05. These statistical treatments were
performed using SPSS v. 23.0.
3. Results and discussion
3.1. Nutritional composition
The results regarding the nutritional composition of the inflor-
escences of C. vulgaris are presented in Table 1. Carbohydrates
were the most abundant macronutrients (83.1 ± 0.3 g per 100
g dw), followed by proteins (8.4 ± 0.3 g per 100 g dw), lipids
(4.42 ± 0.04 g per 100 g dw), and ashes (2.3 ± 0.04 g per 100
g dw). These results are in agreement with Rodrigues et al.,31
who evaluated the nutritional composition of the wild flowers
of C. vulgaris and also identified carbohydrates in higher
amounts (36.2 ± 0.2 g per 100 g dw), followed by proteins
(6.8 ± 0.27 g per 100 g dw), lipids (3.7 ± 0.1 g per 100 g dw),
and ashes (2.3 ± 0.04 g per 100 g dw). Fructose and glucose
were the two identified sugars, glucose being present in higher
amounts (5.36 ± 0.08 g per 100 g dw).
Concerning the organic acid profile (Table 1), it was poss-
ible to identify and quantify oxalic, quinic, ascorbic and citric
acids, citric acid being present in higher content (0.586 ±
0.007 g per 100 g dw), and ascorbic acid in lower amount
(0.0166 ± 0.0001 g per 100 g dw). Ascorbic acid has already
been identified in extracts obtained from C. vulgaris leaves in
amounts of 267.6 mg per 100 g.32 Moreover, quinic acid was
also found in the flowers of this species (27.07 μg mL−1).31
The diﬀerences observed between the results of these authors
and the ones obtained in the present work can be due to
the diﬀerent origins of plant materials, since the inflores-
cences studied in this work were commercially obtained and
the ones reported by the other authors corresponded to wild
samples.
Regarding fatty acid composition (Table 2), twenty-six
diﬀerent compounds were identified in the inflorescences of
C. vulgaris. Linolenic acid (C18:2n6) was the major compound
(21%), followed by palmitic (19.6%) and linoleic (19%) acids,
eicosapentarenoic acid (C20:2) being the minor compound
present (0.089%). The presence of palmitic (C16:0, 21%), lino-
lenic (C18:3n3, 35%) and linoleic (C18:2n6c, 27%) acids as the
major fatty acids present in C. vulgaris flowers was also
reported.31 Moreover, there was a prevalence of polyun-
saturated fatty acids (PUFA) (53%), followed by saturated fatty
acids (SFA) with 39.9% and lastly monounsaturated fatty acids
(MUFA), with 7.1%.
Table 1 Nutritional value, free sugars and organic acids of the inﬂorescences of C. vulgaris
Nutritional value (mg per 100 g dw) Organic acids (g per 100 g dw)
Ash (mg per 100 g dw) 4.06 ± 0.03 Oxalic acid 0.208 ± 0.001
Proteins (mg per 100 g dw) 8.4 ± 0.3 Quinic acid 1.97 ± 0.04
Fat (mg per 100 g dw) 4.42 ± 0.04 Ascorbic acid 0.0166 ± 0.0001
Total carbohydrates (mg per 100 g dw) 83.1 ± 0.3 Citric acid 0.586 ± 0.007
Energy (kcal per 100 g dw) 406.9 ± 0.1 Total organic acids 2.79 ± 0.04
Free sugars (g per 100 g dw)
Fructose 2.92 ± 0.05
Glucose 5.36 ± 0.08
dw – dry weight; results are expressed as the mean value ± standard deviation (SD).
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With respect to tocopherols, all four isoforms of tocopher-
ols were identified with α-tocopherol present in higher content
(5.84 ± 0.07 mg per 100 g dw) and β-tocopherol in lower
amounts (0.250 ± 0.001 mg per 100 g dw). The presence of the
four isoforms in flowers of C. vulgaris was described by
Rodrigues et al.,31 who also stated the highest content in
α-tocopherol (32.5 mg per 100 g) and the lowest amount in
β-tocopherol (0.39 mg per 100 g). The values of our study were
found in lower content, which could be explained by the
diﬀerent origins of these species.
3.2. HPLC-DAD-ESI/MS analysis of phenolic compounds
The peak characteristics and tentative identities of the com-
pounds present in the diﬀerent organic and aqueous extracts
of the aerial parts of C. vulgaris are presented in Table 3.
Twelve compounds were detected, two of which were phenolic
acid derivatives (hydroxycinnamic acid derivatives) and ten fla-
vonoids, particularly nine flavonols and one flavan-3-ol.
Among the phenolic acids, peaks 1 ([M − H]− at m/z 353) and 2
([M − H]− at m/z 289) were positively identified as 5-O-caﬀeoyl-
quinic acid and catechin, respectively, according to their reten-
tion time, mass and UV-vis characteristics in comparison with
the commercial standards. Peak 4 ([M − H]− at m/z 337) was
identified as 5-p-coumaroylquinic acid taking into account the
hierarchical fragmentation pattern described.33 All of the men-
tioned compounds have been previously reported in diﬀerent
plant parts of C. vulgaris.34
The remaining peaks corresponded to flavonol glycoside
derivatives from quercetin (λmax around 350 nm and an MS
2
fragment at m/z 301), kaempferol (λmax around 348 nm, MS
2
fragment at m/z 285), myricetin (λmax around 354 nm, MS
2 frag-
ment at m/z 317), and isorhamnetin (λmax at 354 nm, MS
2 frag-
ment at m/z 315) (Table 3). Peaks 5 (myricetin-3-O-glucoside), 7
(quercetin-3-O-glucoside), and 9 (isorhamnetin-3-O-glucoside)
were positively identified in comparison with the commercial
standard. Compounds 8 and 10 ([M − H]− at m/z 463) were
assigned to quercetin derivatives, while peaks 6 ([M − H]− at
m/z 463), 11 ([M − H]− at m/z 431), and 12 ([M − H]− at m/z
461) were assigned to myricetin, kaempferol and isorhamnetin
derivatives, respectively. They all presented one MS2 fragment,
corresponding to the loss of hexosyl (−162 mu) and rhamnosyl
(−146 mu) moieties, respectively. The elution order was
coherent with the type of sugar substituent and according to
their expected polarity, although the position and nature of
the sugar moieties could not be identified, because their
retention times did not correspond to any of the standards
available.
Diﬀerent quercetin, myricetin, kaempferol, and isorhamne-
tin derivatives have been found in diﬀerent parts of
C. vulgaris.13,31,34 In the present study myricetin-3-O-glucoside
and myricetin-O-rhamnoside were the most abundant com-
pounds present in all the diﬀerent organic and aqueous
extracts, followed by 5-O-caﬀeoylquinic acid in the methanol,
infusion and decoction extracts. To the best of our knowledge,
both main myricetin glycoside derivatives have not been pre-
viously identified in C. vulgaris, only the aglycone having been
identified.34 The decoction revealed the highest concentration
in phenolic compounds, followed by the infusion, methanol,
acetone, ethyl acetate, and finally the hexane extract; there-
fore, the phenolic compound content is higher when solvent
polarity increases. Thus, the dichloromethane extract did
not present any of the identified phenolic compounds. Fig. 1
represents the phenolic profile found in the methanol
extract.
3.3. Bioactive properties
Two methods were used to evaluate the antioxidant activity of
organic and aqueous extracts of C. vulgaris (Table 4). In both
assays, acetone was the most active extract with an EC50 of
8 μg mL−1 for the TBARS and 14 μg mL−1 for the OxHLIA
assay. These EC50 values are higher than the ones exhibited by
Trolox, a recognized antioxidant agent (EC50 of 9.1 μg mL−1
and 21.2 μg mL−1 for the TBARS and the OxHLIA assay,
respectively), highlighting these extracts as a promising source
of compounds with antioxidant potential. In turn, the di-
chloromethane extract revealed the weakest potential, present-
ing no activity in the TBARS assay and an EC50 value of 384
μg mL−1 in the OxHLIA assay. The antioxidant potential is
widely described in the literature, especially the scavenging
capacity through the DPPH assay. To the best of our knowl-
edge, the TBARS assay in C. vulgaris was only evaluated in the
Table 2 Fatty acids and tocopherols identiﬁed in the inﬂorescences of
C. vulgaris
Fatty acids (relative percentage %)
C8:0 0.17 ± 0.01 C20:3n3 11.0 ± 0.5
C10:0 0.17 ± 0.01 C22:0 2.84 ± 0.01
C11:0 0.64 ± 0.03 C22:1 0.178 ± 0.007
C12:0 0.47 ± 0.01 C20:5n3 0.307 ± 0.006
C14:0 1.52 ± 0.06 C22:2 0.669 ± 0.006
C15:0 0.33 ± 0.02 C23:0 5.6 ± 0.3
C16:0 19.6 ± 0.6 C24:0 0.108 ± 0.006
C16:1 1.11 ± 0.03 C24:1 2.40 ± 0.07
C17:0 0.64 ± 0.03 SFA 39.9 ± 0.2
C18:0 5.07 ± 0.02 MUFA 7.05 ± 0.05
C18:1n9c 3.097 ± 0.003 PUFA 53.0 ± 0.2
C18:2n6c 19.2 ± 0.1
C18:3n3 21.0 ± 0.2 Tocopherols (mg per 100 g dw)
C20:0 2.4 ± 0.2 α-Tocopherol 5.84 ± 0.07
C20:1 0.267 ± 0.005 β-Tocopherol 0.2500 ± 0.0001
C20:2 0.089 ± 0.003 γ-Tocopherol 0.75 ± 0.03
C21:0 0.289 ± 0.002 δ-Tocopherol 1.05 ± 0.08
C20:3n6 0.73 ± 0.04 Total tocopherols 8.0 ± 0.2
dw – dry weight; C8:0 – caprylic acid; C10:0 – capric acid; C11:0 –
undecanoic acid; C12:0 – lauric acid; C14:0 – myristic acid; C15:0 –
pentadecanoic acid; C16:0 – palmitic acid; C17:0 –heptadecanoic acid;
C18:0 – stearic acid; C18:1n9 – oleic acid; C18:2n6 – linoleic acid;
C18:3n3 – linolenic acid; C20:0 – arachidic acid; C20:1 – gadoleic acid;
C20:2 – eicosadienoic acid; C21:0 – heneicosanoic acid; C20:3n6 –
eicosatrienoic acid; C20:3n3 – 11,14,17-eicosatrienoic acid; C22:0 –
behenic acid; C22:1 – eicosenoic acid; C20:5n3 – eicosapentaenoic
acid; C22:2 – dodecanoic acid; C23:0 – tricosanoic acid; C24:0 –
lignocéric acid; C24:1 – nervonic acid. SFA – saturated fatty acids;
MUFA – monounsaturated fatty acids; PUFA – polyunsaturated fatty
acids. Results are expressed as the mean values ± standard deviation
(SD).
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Table 3 Retention time (Rt), wavelengths of maximum absorption (λmax), mass spectral data and tentative identiﬁcation of the phenolic compounds present in the organic and aqueous extracts
of C. vulgaris
Peak
Rt
(min)
λmax
(nm)
[M − H]−
(m/z) MS2 (m/z) Tentative identification
Quantification (mg g−1 extract)
n-Hexane Dichloromethane
Ethyl
acetate Acetone Methanol Decoction Infusion
1 7.07 325 353 191(100), 179(5),
173(2), 135(2)
5-O-Caﬀeoylquinic
acid1
n.d. n.d. n.d. 0.20 ±
0.02c
3.3 ± 0.1b 3.1 ± 0.2b 5.0 ± 0.2q
2 7.15 275 289 245(100), 203(5),
137(2)
(+)-Catechin2 n.d. n.d. 0.52 ± 0.09 n.d. n.d. n.d. n.d.
3 11.15 334 479 317(100) Myricetin-O-hexoside3 n.d. n.d. n.d. 2.12 ±
0.02c
2.09 ± 0.01c 4.50 ± 0.03a 4.34 ±
0.02b
4 11.88 310 337 191(100), 173(16),
163(6)
5-p-Coumaroylquinic
acid4
n.d. n.d. n.d. n.d. 0.10 ± 0.01b 0.06 ± 0.01c 0.150 ±
0.001a
5 15.23 356 479 317(100) Myricetin-3-O-
glucoside3
1.672 ±
0.001e
n.d. 1.63 ± 0.07e 4.96 ±
0.09d
4.30 ± 0.09c 5.80 ± 0.01b 8.1 ± 0.1a
6 17.85 349 463 317(100) Myricetin-O-
rhamnoside3
1.668 ±
0.001e
n.d. 1.66 ± 0.09e 2.04 ±
0.06b
2.81 ± 0.05c 4.86 ± 0.06b 5.8 ± 0.1a
7 18.68 354 463 301(100) Quercetin-3-O-
glucoside5
0.310 ±
0.001d
n.d. 0.37 ± 0.03d 2.20 ±
0.06b
1.680 ±
0.004c
1.650 ±
0.001c
3.01 ±
0.08a
8 19.08 354 463 301(100) Quercetin-O-hexoside5 0.3080 ±
0.0002e
n.d. 0.3550 ±
0.0003e
0.800 ±
0.002d
0.97 ± 0.07c 1.22 ± 0.03b 2.05 ±
0.09a
9 22.44 337 477 315(100) Isorhamnetin-3-O-
glucoside5
0.3100 ±
0.0002f
n.d. 1.6 ± 0.3d 1.25 ±
0.08e
2.8 ± 0.1b 2.33 ± 0.03c 5.48 ±
0.08a
10 26.42 343 463 301(100) Quercetin-O-hexoside5 n.d. n.d. 0.298 ±
0.005e
0.42 ±
0.03c
0.350 ±
0.005d
0.810 ±
0.001a
0.77 ±
0.01b
11 27.30 341 431 285(100) Kaempferol-O-
rhamnoside5
n.d. n.d. 0.36 ± 0.04b n.d. 0.39 ± 0.01b 0.830 ±
0.003a
0.81 ±
0.01a
12 28.38 345 461 315(100) Isorhamnetin-O-
rhamnoside5
0.3070 ±
0.0001e
n.d. 0.428 ±
0.001d
0.41 ±
0.01d
0.53 ± 0.01c 0.92 ± 0.01b 1.12 ±
0.03a
Total phenolic acids n.d. n.d. n.d. 0.20 ±
0.02c
3.4 ± 0.1b 3.2 ± 0.2b 5.1 ± 0.2a
Total flavonoids 4.570 ±
0.001f
n.d. 6.6 ± 0.5e 13.2 ± 0.1d 15.9 ± 0.2c 22.92 ±
0.01b
31.5 ± 0.5a
Total phenolic
compounds
4.570 ±
0.001f
n.d. 7.2 ± 0.4e 13.39 ±
0.09d
19.31 ±
0.02c
26.1 ± 0.2b 36.6 ± 0.7a
n.d. – not detected. Calibration curves: 1 – caﬀeic acid (y = 388345x + 406.369, R2 = 0.994); 2 − (+)-catechin (y = 84950x − 23 200, R2 = 0.999); 3 – myricetin (y = 23287x − 581 708, R2 = 0.9988);
4 – p-coumaric acid (y = 301950x + 6966.7, R2 = 0.999); 5 – quercetin-3-O-glucoside (y = 34843x − 160 173, R2 = 0.9988). Results are expressed as the mean values ± standard deviation (SD).
Diﬀerent letters correspond to significant diﬀerences (p < 0.05).
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petroleum ether extract of the roots of this species; at a con-
centration of 25 µg mL−1 the TBARS inhibition was about
20%.8
The highest levels of phenolic compounds found in this
species have been correlated to the antioxidant activity.6,35
Nevertheless, in the present study the extracts with the highest
phenolic compound content (decoction and infusion extracts)
were not the most active regarding the antioxidant properties,
whereas the acetone extract revealed the highest potential.
This fact can be due to the antioxidant activity of other less
polar compounds extracted with acetone.
All the extracts were also evaluated regarding LPS-induced
NO production in the murine macrophage (RAW 264.7) cell
line and the results are presented in Table 4. Nitric oxide (NO)
has an important role in the inflammatory process; thus,
obtaining compounds with a high capacity to inhibit NO pro-
duction is a promising advance in the development of active
formulations. All the tested extracts showed anti-inflammatory
capacity with EC50 values between 66 and 297 µg mL
−1. In
general, an increase in the polarity solvent decreased the anti-
inflammatory potential, suggesting that the phytochemical
constituents responsible for this biological potential are less
Fig. 1 Phenolic compound proﬁle of the methanolic extract of C. vulgaris at 280 nm (A) and 370 nm (B). Numbers correspond to peak identiﬁcation
in Table 3.
Table 4 Antioxidant, anti-inﬂammatory and cytotoxic activities of C. vulgaris
n-Hexane Dichloromethane Ethyl acetate Acetone Methanol Decoction Infusion
Antioxidant activity (EC50, µg mL
−1)
TBARS 95 ± 4a n.d. 33 ± 3e 8 ± 0.2f 53 ± 1c 79 ± 2b 61 ± 1d
OxHLIA (Δt = 60 min) 320 ± 10b 384 ± 10a 80 ± 2c 14 ± 0.4e 34 ± 0.6d 38 ± 1d 66 ± 0.3c
Anti-inflammatory activity (EC50, µg mL
−1)
RAW 246.7 66 ± 3e 81 ± 3de 81 ± 6de 90 ± 4c 189 ± 3b 280 ± 13a 297 ± 17a
Cytotoxic activity (GI50, µg mL
−1)
AGS 58 ± 5e 106 ± 9c 49 ± 4e 100 ± 6c 78 ± 4d 281 ± 12b 305 ± 10a
MCF-7 41 ± 4d 101 ± 5b 40 ± 3d 89 ± 5bc 65 ± 4cd 353 ± 32a 351 ± 6a
NCI-H460 61 ± 3d 133 ± 6a 50 ± 1e 121 ± 4b 101 ± 9c n.d. n.d.
HeLa 33 ± 2d 83 ± 3c 31± 3d 69 ± 5c 76 ± 6c 224 ± 22b 258 ± 14a
HepG2 43 ± 4e 120 ± 12c 44 ± 1e 145 ± 12b 97 ± 6d 368 ± 23a 352 ± 7a
PLP2 61 ± 3d 240 ± 8a 41 ± 2e 198 ± 5b 163 ± 8c >400 >400
EC50 values corresponded to the extract concentration that inhibits in 50% the oxidation and inflammatory process. Trolox (EC50 values): TBARS:
9.1 ± 0.3; OxHLIA: 21.2 ± 0.7. Dexametasona (IC50 values): 16 ± 1. GI50 values correspond to the concentration that causes 50% inhibition of cell
proliferation; n.d. – not detected; AGS – human gastric adenocarcinoma; MCF-7 – human breast adenocarcinoma; NCI-H460 – human lung carci-
noma; HeLa – human cervix adenocarcinoma; HepG2 – hepatocellular carcinoma; PLP2 – primary culture of non-tumoral pig liver cells.
Ellipticine (GI50 values). AGS: 2.59 ± 0.05; MCF-7: 1.21 ± 0.02; NCI-H460: 0.91 ± 0.11; HeLa: 1.03 ± 0.09; HepG2: 1.1 ± 0.09; PLP2: 2.29 ± 0.18.
Results are expressed as the mean values ± standard deviation (SD). Diﬀerent letters represent significant diﬀerences (p < 0.05).
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Table 5 Antibacterial activity associated with organic and aqueous extracts of C. vulgaris
n-Hexane Dichloromethane Ethyl acetate Acetone Methanol Decoction Infusion
Ampicillin
(20 mg mL−1)
Imipenem
(1 mg mL−1)
Vancomicin
(1 mg mL−1)
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Pathogenic
Gram-negative
Escherichia coli 20 >20 20 >20 20 >20 5 >20 2.5 >20 2.5 >20 2.5 >20 <0.15 <0.15 <0.0078 <0.0078 n.t. n.t.
Klebsiella
pneumoniae
20 >20 20 >20 20 >20 5 >20 2.5 >20 2.5 >20 2.5 >20 10 20 <0.0078 <0.0078 n.t. n.t.
Morganella
morganii
20 >20 5 >20 5 >20 5 >20 2.5 >20 2.5 >20 2.5 >20 20 >20 <0.0078 <0.0078 n.t. n.t.
Proteus
mirabilis
>20 >20 10 >20 20 >20 10 >20 20 >20 10 >20 20 >20 <0.15 <0.15 <0.0078 <0.0078 n.t. n.t.
Pseudomonas
aeruginosa
20 >20 20 >20 20 >20 5 20 10 >20 10 >20 10 >20 >20 >20 0.5 1 n.t. n.t.
Neisseria
gonorrohoeae
n.t. n.t. n.t. n.t. n.t. n.t. 2.5 >20 5 >20 2.5 >20 2.5 >20 <0.15 <0.15 n.t. n.t. n.t. n.t.
Gram-positive
Enterococcus
faecalis
>20 >20 5 >20 20 >20 2.5 >20 10 >20 20 >20 10 >20 <0.15 <0.15 n.t. n.t. <0.0078 <0.0078
Listeria
monocytogenes
>20 >20 20 >20 10 20 2.5 >20 2.5 >20 2.5 >20 2.5 >20 <0.15 <0.15 n.t. n.t. n.t. n.t.
MRSA 20 20 10 20 20 20 1.25 >20 1.25 20 1.25 20 1.25 20 <0.15 <0.15 n.t. n.t. <0.0078 <0.0078
MSSA 10 20 0.6 20 0.15 20 0.6 20 0.15 20 <0.15 20 0.15 20 <0.15 <0.15 n.t. n.t. 0.25 0.5
Variable gram
Gardnerella
vaginallis
n.t. n.t. n.t. n.t. n.t. n.t. 5 n.t. 5 n.t. 5 n.t. 5 n.t. <0.15 <0.15 n.t. n.t. n.t. n.t.
Non-pathogenic
L delbrueckii n.t. n.t. n.t. n.t. n.t. n.t. 10 n.t. 20 n.t. 10 n.t. 10 n.t. <0.15 <0.15 n.t. n.t. n.t. n.t.
L. casei n.t. n.t. n.t. n.t. n.t. n.t. 10 n.t. >20 n.t. 10 n.t. 10 n.t. <0.15 <0.15 n.t. n.t. n.t. n.t.
L. plantarum n.t. n.t. n.t. n.t. n.t. n.t. 20 n.t. >20 n.t. 10 n.t. 10 n.t. <0.15 <0.15 n.t. n.t. n.t. n.t.
MIC – minimal inhibitory concentration; MBC – minimal bactericidal concentration; n.t. – not tested; MRSA – methicillin resistant Staphylococcus aureus; MSSA – methicillin sensitive Staphylococcus aureus.
Fo
o
d
&
Fu
n
ctio
n
P
ap
e
r
T
h
is
jo
u
rn
alis
©
Th
e
R
o
yalSo
ciety
o
f
C
h
em
istry
20
19
Fo
o
d
Fu
n
ct.,20
19
,10
,78
–8
9
|
8
5
P
u
b
l
i
s
h
e
d
 
o
n
 
2
0
 
N
o
v
e
m
b
e
r
 
2
0
1
8
.
 
D
o
w
n
l
o
a
d
e
d
 
o
n
 
1
2
/
1
8
/
2
0
1
9
 
1
2
:
2
7
:
5
7
 
P
M
.
 
View Article Online
polar. Accordingly, the n-hexane extract was the one exhibiting
the highest activity (EC50 = 66 ± 3 µg mL
−1). The decoction and
infusion extracts presented the highest EC50 values (280 ± 13
and 297 ± 17 µg mL−1, respectively), presenting the weakest
potential. The anti-inflammatory activity of the diﬀerent con-
stituents of C. vulgaris has already been demonstrated through
diﬀerent biological assays, such as the capacity to stabilize the
HRBC membrane and to scavenge NO and in vivo assays with
the induction of inflammation in mice,13 and the ability to
suppress the signaling of a nuclear factor (NF-KB).36
Nevertheless, an evaluation on the RAW 264.7 cell line was not
reported until now.
The results obtained for the five human tumor cell lines
and for the primary culture cell line are presented in Table 4.
All the tested extracts demonstrated cytotoxic activity for
almost all the analyzed cell lines, except for the aqueous
extracts that presented no activity against the lung tumor cell
line (NCI-H460). HeLa was the most susceptible cell line, pre-
senting GI50 ranging from 33 to 83 µg mL
−1 for the organic
extracts, and 224 to 258 µg mL−1 for the aqueous extracts. The
n-hexane and the ethyl acetate extracts were the most active
against all the tested cell lines, presenting GI50 values in the
range of 33–61 µg mL−1 and 31–50 µg mL−1, respectively.
Nevertheless, regarding the cytotoxic eﬀects on normal cells,
these were also the extracts presenting the strongest activity, in
some cases presenting the same GI50 values as the ones
needed to inhibit the tumor cell growth. In this perspective,
among the most active extracts, it can be considered that the
acetone and the methanol extracts are the most promising can-
didates to be applied in this field, since the GI50 values needed
to inhibit the tumor cells are significantly lower than the ones
needed to inhibit the normal cells (Table 4).
The cytotoxic activity of diﬀerent extracts from the aerial
parts of C. vulgaris obtained by sequential percolation and
with solvents of diﬀerent polarities (n-hexane, chloroform,
ethyl acetate, methanol, water) was evaluated in a rat mela-
noma (B16) cell line.16 These authors described that the
extracts with lower polarity presented better results, whereas
the aqueous extracts were less active, which is in agreement
with the results obtained in the present work. In another
study,14 which studied C. vulgaris extracted under moderate
pressure conditions (30 MPa), triterpenoids, namely ursolic
and oleanolic acids, were identified as the major compounds.
These compounds have also been described as being respon-
sible for the cytotoxic eﬀects of C. vulgaris not only against
breast cancer (MCF-7), mouse melanoma (B16F10), glioma
(U87-MG), hepatic cancer (Hep-G2), and leukemic cells
(HL-60),17 but also against normal kidney cells of monkeys.37
One of the ethnopharmacological applications of C. vulgaris
most frequently described in the literature is in the treatment
of infections related to the urinary tract. As a result of this
important activity, the extracts obtained were tested against
twelve bacterial strains, which could be responsible for infec-
tions of the urogenital tract. The results for the diﬀerent tested
extracts are presented in Table 5, and the results are expressed
as MIC values (mg mL−1). In general, all the extracts showed
inhibiting potential against the pathogenic bacteria. The
Gram-positive bacteria presented lower MIC values, being the
most susceptible strains when compared with the Gram-nega-
tive strains. The most polar extracts revealed the highest anti-
bacterial activity, such as decoction and infusion, and the
opposite eﬀect was observed for the extracts such as the
n-hexane, dichloromethane and ethyl acetate extracts, which
revealed the weakest potential. The n-hexane extract was the
weakest extract, presenting the highest MIC values, while the
methanol, acetone and aqueous extracts exhibited the stron-
gest antibacterial capacity with lower MIC values. The decoc-
tion was the one presenting the most interesting potential,
with lower MIC and MBC values for almost all the bacterial
strains tested, with the exception of Pseudomonas aeroginosa
and Enterococcus faecalis, for which the most active extract was
acetone. This fact corroborates the knowledge applied in tra-
ditional medicine, since the infusions and decoctions of this
species are traditionally used for the treatment of diﬀerent
infections, as previously mentioned.
Diﬀerent authors described that the extracts of C. vulgaris
presented no activity against some of the bacterial strains
tested in the present work, such as Escherichia coli,8,9,31,35
Klebsiella pneumoniae,9,31 Pseudomonas aeruginosa,9,31,35 methi-
cillin-resistant Staphylococcus aureus (MRSA) and Proteus mir-
abilis.35 This fact can be justified by the use of diﬀerent parts
of C. vulgaris, since these authors used the seeds and roots.
Most of the results described in the literature evaluate the
activity of organic extracts.10,31 The antibacterial activity associ-
ated with aqueous, ethanolic and hydroethanolic extracts of
wild C. vulgaris flowers were studied against seven bacterial
strains: Staphylococcus epidermidis, Staphylococcus aureus,
MRSA, Pseudomonas aeroginosa, Escherichia coli, Klebsiella
pneumoniae and Candida albicans.31 In contrast to the present
work, the extract that showed the best activity was the hydro-
ethanolic (MIC 2.0–8.5 mg mL−1), and the extract with the
lowest potential was the ethanolic (MIC 10.8–43.2 mg mL−1).
Infusions obtained with water, ethanol and ethyl acetate were
tested against three diﬀerent bacteria: Escherichia coli,
Enterococcus faecalis and Proteus vulgaris, describing that the
aqueous extract was the most active and the ethyl acetate was
the weakest.10 These results are in agreement with the ones
obtained in the present work.
The eﬀects on the vaginal microbiota were studied using
bacteria belonging to the vaginal microbiota that have a direct
eﬀect on the host, since they have the ability to protect the
organism from possible infections as a result of the anti-
microbial eﬀect they exert against pathogenic organisms. This
ability derives from the production of substances such as
lactic acid, bacteriocins and hydrogen peroxide, mainly by
Lactobacillus.38 Each of these compounds eﬀectively has the
ability to kill pathogenic substances:39 lactic acid allows the
maintenance of a low vaginal pH, between 3.5 and 4.5, limit-
ing the growth of potentially dangerous microorganisms; bac-
teriocins inhibit the growth of several bacteria including
Gardnerella vaginalis; and finally, hydrogen peroxide has the
ability to inhibit some Gram-negative bacteria, such as
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Pseudomonas aeruginosa, and Gram-positive bacteria, such as
Staphylococcus aureus.40,41
As a result of the promising antibacterial activity associated
with some of the tested extracts (acetone, methanol, decoction
and infusion), and based on the knowledge of traditional
medicine, the antibacterial activity of these extracts was also
evaluated in the vaginal microbiota (Table 5). Gardnerella vagi-
nalis and Neisseria gonorrhoeae are the strains usually associ-
ated with bacterial vaginosis, a vaginal infection that occurs
when the vaginal microbiota suﬀers an imbalance, namely
with the decrease of Lactobacillus.38 In this perspective, the
main objective was to demonstrate that the extracts present
the ability to inhibit these bacteria without aﬀecting
Lactobacillus strains. Through the comparison of the results
for pathogenic and non-pathogenic strain bacteria, it is poss-
ible to state that MIC values presented by the extracts are
higher for the Lactobacillus strains compared to the ones
needed to inhibit the pathogenic microorganisms, with the
exception of Proteus mirabilis, Pseudomonas aeruginosa and
Enterococcus faecalis.
From Table 5 it is possible to visualize that for a MIC of
5 mg mL−1 the majority of the pathogenic strains are inhib-
ited, without aﬀecting Lactobacillus strains that showed a
higher MIC value (≥10 mg mL−1). Regarding the microorgan-
isms belonging to the vaginal microbiota, MIC values for
Gardnerella vaginalis and Neisseria gonorrhoeae are lower than
those exhibited for Lactobacillus, which allows the inhibition
of the pathogens without aﬀecting beneficial bacterial strains.
It can be highlighted that the methanolic and acetone extracts
revealed the best potential, by inhibiting Gardnerella vaginalis
and Neisseria gonorrhoeae MIC values of 5 and 2.5 mg mL−1,
respectively, and presenting a much higher MIC value for all
the Lactobacillus strains (20 mg mL−1).
To the best of our knowledge, there is no report in the lit-
erature regarding the antibacterial activity of C. vulgaris
extracts relative to the vaginal microbiota. However, a study
recently published,42 also using a natural product, has shown
that it is possible to inhibit vaginal Gardnerella without inter-
fering with the vaginal microbiota.
4. Conclusions
C. vulgaris was evaluated regarding its nutritional value and
chemical composition. Moreover, five organic and two
aqueous extracts were obtained from inflorescences of
C. vulgaris by extraction with solvents of diﬀerent polarities,
which were fully characterized regarding their phenolic com-
position and their biological eﬀects evaluated. From a nutri-
tional point of view, carbohydrates were the major compounds
found in C. vulgaris, followed by proteins, lipids and ashes.
Fructose and glucose were the only sugars identified with
glucose predominating. Five organic acids were also quanti-
fied, citric acid being present in the highest amount.
Regarding fatty acids, twenty-six compounds were identified,
PUFA being the most predominant fatty acid. The four iso-
forms of tocopherol were identified, α-tocopherol being the
most abundant. Furthermore, twelve phenolic compounds
were identified in the extracts, myricetin-3-O-glucoside and
myricetin-O-rhamnoside being the main molecules present.
The obtained extracts revealed diﬀerent biological potentials
according to the studied biological properties. Most polar
extracts, such as the methanolic, acetone and aqueous extracts,
showed the strongest potential for the antioxidant and antibac-
terial activities and the highest content of phenolic com-
pounds. In contrast, for the anti-inflammatory and cytotoxic
eﬀects, the n-hexane extract was the most eﬀective. Overall, it
should be stated that the inflorescences of C. vulgaris pre-
sented huge potential in terms of bioactivity, especially against
a range of pathogenic bacteria strains, and most importantly,
without aﬀecting normal vaginal microbiota, highlighting
their potential for application in the pharmaceutical sector.
Moreover, the obtained results corroborate the use of the
aqueous extracts in traditional medicine.
Conﬂicts of interest
There are no conflicts to declare.
Acknowledgements
The authors are grateful to the Foundation for Science and
Technology (FCT, Portugal) and FEDER under Programme
PT2020 for financial support through CIMO (UID/AGR/00690/
2013), CQ-VR (UID/QUI/00616/2013), and S. Heleno (SFRH/
BPD/101413/2014) grants, and L. Barros and R. C. Calhelha
contracts. The authors are also grateful to the FEDER-Interreg
España-Portugal programme for financial support through the
project 0377_Iberphenol_6_E. The authors are thankful to
Dr Ana Maria Carvalho from the Instituto Politécnico de
Bragança for her botanical expertise.
References
1 N. Martins and I. C. F. R. Ferreira, Mountain food products:
A broad spectrum of market potential to be exploited,
Trends Food Sci. Technol., 2017, 67, 12–18.
2 Plants for a Future, https://pfaf.org/user/Plant.aspx?
LatinName=Calluna+vulgaris, (accessed October 2018).
3 O. Escuredo, M. Míguez, M. Fernández-González and
M. C. Seijo, Nutritional value and antioxidant activity of
honeys produced in a European Atlantic area, Food Chem.,
2013, 138, 851–856.
Food & Function Paper
This journal is © The Royal Society of Chemistry 2019 Food Funct., 2019, 10, 78–89 | 87
Pu
bl
ish
ed
 o
n 
20
 N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
2/
18
/2
01
9 
12
:2
7:
57
 P
M
. 
View Article Online
4 K. Ghedira and P. Goetz, Bruyère commune: Calluna
vulgaris (L.) Hull ou Calluna vulgáris Salisb. (Ericaceae),
Phytotherapie, 2013, 11, 52–55.
5 J. M. Neves, C. Matos, C. Moutinho, G. Queiroz and
L. R. Gomes, Ethnopharmacological notes about ancient
uses of medicinal plants in Trás-os-Montes (northern of
Portugal), J. Ethnopharmacol., 2009, 124, 270–283.
6 M. Monschein, J. I. Neira, O. Kumert and F. Bucar,
Phytochemistry of heather (Calluna vulgaris (L.) Hull) and
its altitudinal alteration, Phytochem. Rev., 2010, 9, 205–
215.
7 A. Chevallier, The Encyclopedia of Medicinal Plants, Dorling
Kindersley, London, 1996.
8 D. A. Ghareeb, A. M. D. ElAhwany, S. M. El-mallawany and
A. A. Saif, In vitro screening for anti-acetylcholiesterase,
anti-oxidant, anti-glucosidase, anti-inflammatory and anti-
bacterial eﬀect of three tradicional medicinal plants,
Biotechnol. Biotechnol. Equip., 2014, 28, 1155–1164.
9 D. Pavlović, B. Lakušić, D. Kitić, M. Milutinović, M. Kostić,
B. Miladinović and N. Kovačević, Antimicrobial activity of
selected plant species of genera Arbutus L., Bruckenthalia,
Rchb., Calluna Salisb. and Erica L. (Ericaceae), Acta Fac.
Med. Naissensis, 2014, 31, 81–85.
10 D. M. Vučić, M. R. Petković, B. B. Rodić-Grabovac,
O. D. Stefanović, S. M. Vasić and L. R. Čomić, In vitro
activity of heather [Calluna vulgaris (L.) Hull] extracts on
selected urinary tract pathogens, Bosn. J. Basic. Med. Sci.,
2014, 14, 234–238.
11 G. A. Filip, I. D. Postescu, C. Tatomir, A. Muresan and
S. Clichici, Calluna vulgaris extract modulates NF-kB/ERK
signaling pathway and matrix metalloproteinase expression
on SKH-1 hairless mice skin exposed to ultraviolet B
irradiation, J. Physiol. Pharmacol., 2012, 63, 423–432.
12 G. Rieger, M. Müller, H. Guttenberger and F. Bucar,
Influence of altitudinal variation on the content of pheno-
lic compounds in wild populations of Calluna vulgaris,
Sambucus nigra, and Vaccinium myrtillus, J. Agric. Food
Chem., 2008, 56, 9080–9086.
13 I. Orhan, E. Küpeli, S. Terzioglu and E. Yesilada, Bioassay-
guided isolation of kaempferol-3-O-ß-D-galactoside with
anti-inflammatory and antinociceptive activity from the
aerial part of Calluna vulgaris L, J. Ethnopharmacol., 2007,
114, 32–37.
14 M. R. García-Risco, E. Vázquez, J. Sheldon, E. Steinmann,
N. Riebesehl, T. Fornari and G. Reglero, Supercritical fluid
extraction of heather (Calluna vulgaris) and evaluation of
anti-hepatitis C virus activity of the extracts, Virus Res.,
2014, 198, 9–14.
15 L. Saaby, H. B. Rasmussen and A. K. Jäger, MAO-A innhibi-
tory activity of quercetin from Calluna vulgaris (L.) Hull,
J. Ethnopharmacol., 2009, 121, 178–181.
16 C.-A. Calliste, P. Trouillas, D.-P. Allais, A. Simon and
J.-L. Duroux, Free radical scavenging activities measured by
electron spin resonance spectroscopy and B16 cell antipro-
liferative behaviors of seven plants, J. Agric. Food Chem.,
2001, 49, 3321–3327.
17 W. Hai, H. Chen, M. Zhao, Y. Wang, L. Hong, H. Tang and
X. Tian, Two new cytotoxic triterpenoid saponins from the
roots of Clematis argentilucida, Fitoterapia, 2012, 83, 759–
764.
18 M. Chudzik, I. Korzonek-Szlacheta and W. Król,
Triterpenes as potentially cytotoxic compounds, Molecules,
2015, 20, 1610–1625.
19 G. Y. Starchenko and A. R. Grytsyk, Analysis of amino acid
composition of Calluna vulgaris, L. (Hull), Pharm. Innov. J.,
2017, 6, 88–89.
20 AOAC, Oﬃcial methods of analysis of AOAC international,
ed. W. George and G. W. Latimer Jr., AOAC International,
Gaithersburg, MD, 20th edn, 2016.
21 H. P. Souza, R. C. G. Corrêa, L. Barros, R. C. Calhelha,
C. Santos-Buelga, R. M. Peralta, A. Bracht, M. Matsushita
and I. C. F. R. Ferreira, Phytochemicals and bioactive pro-
perties of Ilex paraguariensis: An in vitro comparative study
between the whole plant, leaves and stems, Food Res. Int.,
2015, 78, 286–294.
22 L. Barros, C. Pereira and I. C. F. R. Ferreira, Bioactivity and
chemical characterization in hydrophilic and lipophilic
compounds of Chenopodium ambrosioides L, Food Anal.
Methods, 2013a, 6, 309–316.
23 L. Barros, E. Pereira, R. C. Calhelha, M. Dueñas,
A. M. Carvalho, C. Santos-Buelga and I. C. F. R. Ferreira,
Optimized analysis of organic acids in edible mushrooms
from Portugal by ultra fast liquid chromatography and
photodiode array detection, J. Funct. Foods, 2013b, 5, 1732–
1740.
24 V. C. Graça, L. Barros, R. C. Calhelha, M. I. Dias,
A. M. Carvalho, C. Santos-Buelga, I. C. F. R. Ferreira and
P. F. Santos, Chemical characterization and bioactive pro-
perties of Geranium molle L.: from the plant to the most
active extract and its phytochemicals, Food Funct., 2016, 7,
2204–2212.
25 S. M. F. Bessada, J. C. M. Barreira, L. Barros, I. C. F.
R. Ferreira and B. P. P. Oliveira, Phenolic profile and anti-
oxidant activity of Coleostephus myconis (L.) Rchb.f.: An
underexploited and highly disseminated species, Ind. Crops
Prod., 2016, 89, 45–51.
26 F. Souilem, Â. Fernandes, R. C. Calhelha, J. C. Barreira,
L. Barros, F. Skhiri, A. Martins and I. C. F. R. Ferreira, Wild
mushrooms and their mycelia as sources of bioactive com-
pounds: Antioxidant, anti-inflammatory and cytotoxic pro-
perties, Food Chem., 2017, 230, 40–48.
27 B. C. Evans, C. E. Nelson, S. S. Yu, K. R. Beavers, A. J. Kim,
H. M. Nelson, T. D. Giorgio and C. L. Duvall, Ex vivo red
blood cell hemolysis assay for the evaluation of pH-
responsive endosomolytic agents for cytosolic delivery of
biomacromolecular drugs, J. Visualized Exp., 2013, 73,
e50166.
28 J. Takebayashi, N. Iwahashi, Y. Ishimi and A. Tai,
Development of a simple 96-well plate method for evalu-
ation of antioxidant activity based on the oxidative haemo-
lysis inhibition assay (OxHLIA), Food Chem., 2012, 134,
606–610.
Paper Food & Function
88 | Food Funct., 2019, 10, 78–89 This journal is © The Royal Society of Chemistry 2019
Pu
bl
ish
ed
 o
n 
20
 N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
2/
18
/2
01
9 
12
:2
7:
57
 P
M
. 
View Article Online
29 F. Sobral, A. Sampaio, S. Falcão, M. J. Queiroz,
R. C. Calhelha, M. Vilas-Boas and I. C. F. R. Ferreira,
Chemical characterization, antioxidant, anti-inflammatory
and cytotoxic properties of bee venom collected in
Northeast Portugal, Food Chem. Toxicol., 2016, 94, 172–
177.
30 J. Glamočlija, D. Stojković, M. Nikolić, A. Ćirić, F. S. Reis,
L. Barros, I. C. F. R. Ferreira and M. Soković, A comparative
study on edible Agaricus mushrooms as functional foods,
Food Funct., 2015, 6, 1900–1910.
31 F. Rodrigues, T. Moreira, D. Pinto, F. B. Pimentel, A. Costa,
M. A. Nunes, T. G. Albuquerque, H. S. Costa, A. Palmeira-
de-Oliveira, A. I. Oliveira, S. Sut, S. Dall’Acqua and
M. B. Oliveira, The phytochemical and bioactivity profiles
of wild Calluna vulgaris L. flowers, Food Res. Int., 2018, 111,
724–731.
32 E. Jones and R. E. Hughes, Foliar ascorbic acid in some
Angiosperms, Phytochemistry, 1983, 22, 2493–2499.
33 M. N. Cliﬀord, K. L. Johnston, S. Knight and N. Kuhnert,
Hierarchical scheme for LC-MSn identification of chloro-
genic acids, J. Agric. Food Chem., 2003, 51, 2900–2911.
34 M. A. F. Jalal, D. J. Read and E. Haslam, Phenolic compo-
sition and its seasonal variation in Calluna vulgaris,
Phytochemistry, 1982, 21, 1397–1401.
35 Y. Kumarasamy, P. J. Cox, M. Jaspars, L. Nahar and
S. D. Sarker, Screening seeds of Scottish plants for antibac-
terial activity, J. Ethnopharmacol., 2002, 83, 73–77.
36 A. Salminen, M. Lehtonen, T. Suuronen, K. Kaarninanta
and J. Huuskonen, Terpenoids: natural inhibitors of NF-kB
signaling with anti-inflammatory and anticancer potencial,
Cell. Mol. Life Sci., 2008, 65, 2979–2999.
37 T. A. Mokota, L. J. McGraw, L. K. Mdee, V. P. Bagla,
E. O. Iwalewa and J. N. Eloﬀ, Antimicrobial activity and
cytotoxic of triterpenes isolated from leaves of Maytenus
undata (Celastraceae), BMC Complementary Altern. Med.,
2013, 13, 111.
38 B. Ma, L. J. Forney and J. Ravel, Vaginal microbiome:
rethinking health and disease, Annu. Rev. Microbiol., 2012,
66, 371–389.
39 C. Mishra and J. Lambert, Production of anti-microbial
substances by probiotics, Asia Pac. J. Clin. Nutr., 1996, 5,
20–24.
40 R. Brunelli, M. Papi, G. Arcovito, A. Bompiani,
M. Castagnola, T. Parasassi, B. Sampaolese, F. Vincenzoni
and M. De Spirito, Globular structure of human ovulatory
cervical mucus, FASEB J., 2007, 21, 3872–3876.
41 B. Huang, J. M. Fettweis, J. P. Brooks, K. K. Jeﬀerson and
G. A. Buck, The changing landscape of the vaginal micro-
biome, Clin. Lab. Med., 2014, 34, 747–761.
42 D. Machado, C. Gaspar, A. Palmeira-de-Oliveira,
C. Cavaleiro, L. Salgueiro, J. Martinez-de-Oliveira and
N. Cerca, Thymbra capitata essential oil as potential thera-
peutic agent against Gardnerella vaginalis biofilm-related
infections, Future Microbiol., 2017, 12, 407–416.
Food & Function Paper
This journal is © The Royal Society of Chemistry 2019 Food Funct., 2019, 10, 78–89 | 89
Pu
bl
ish
ed
 o
n 
20
 N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
2/
18
/2
01
9 
12
:2
7:
57
 P
M
. 
View Article Online
